バイオバンキング機器市場レポート：動向、予測、競合分析 (2031年まで)

世界のバイオバンキング機器市場の将来は、製薬、バイオバンク、病院、契約研究機関市場に機会があり、有望視されています。世界のバイオバンキング機器市場は、2025年から2031年までのCAGRが4.1%で、2031年までに推定520億米ドルに達すると予想されています。この市場の主な促進要因は、バイオバンクへの投資と資金調達の拡大、慢性疾患の有病率の上昇、個別化医療の需要拡大です。

• Lucintel社の予測では、用途別では再生医療分野が予測期間中に最も高い成長を遂げる見込みです。
• エンドユースカテゴリーでは、受託研究機関が予測期間中に最も高い成長を遂げる見込みです。
• 地域別では、北米が予測期間中最大の地域であり続けます。

バイオバンキング機器市場の戦略的成長機会

バイオバンキング機器市場は、さまざまな用途においていくつかの戦略的成長機会を提示しています。これらの機会はイノベーションを促進し、バイオバンキングサービスの範囲を拡大しています。

• ゲノミクス調査：バイオバンクは、先進的な機器とデータ管理ソリューションによって、ますますゲノム研究をサポートするようになっています。この機会には、個別化医療や精密研究をサポートするためのゲノムデータとバイオバンク・試料の統合も含まれます。
• 臨床試験：バイオバンクは試料の収集と分析に重要なサポートを提供するため、臨床試験におけるバイオバンキング機器の需要は高まっています。この機会には、臨床研究のための試料処理とデータ統合の強化が含まれます。
• 再生医療：バイオバンクは、研究開発に高品質の生物学的試料を提供することにより、再生医療において重要な役割を果たしています。この機会には、再生療法のための高度な保管・保存技術の開発が含まれます。
• 医薬品開発：バイオバンク市場は、前臨床試験や臨床試験に生物学的試料を供給することで医薬品開発を支援しています。成長機会としては、医薬品研究のための試料品質の向上やデータ管理の合理化などが挙げられます。
• 公衆衛生研究：バイオバンクは、疫学研究や疾病モニタリングのための試料提供など、公衆衛生研究に不可欠です。成長機会には、バイオバンク・ネットワークの拡大や、公衆衛生イニシアチブのためのデータ・アクセシビリティの向上が含まれます。

このような成長機会はバイオバンクの能力を高め、多様な研究用途をサポートし、市場拡大の原動力となっています。

バイオバンキング機器市場の市場促進要因・課題

バイオバンキング機器市場は、その成長と開拓に影響を与える様々な促進要因・課題の影響を受けています。これらの要因を理解することは、市場を効果的にナビゲートする上で極めて重要です。

バイオバンキング機器市場の促進要因には以下のようなものがある：

• 個別化医療に対する需要の高まり：個別化医療への注目の高まりにより、ゲノム研究や臨床研究をサポートする高度なバイオバンキング機器へのニーズが高まっています。
• 技術の進歩：凍結保存、自動化、データ管理における技術革新がバイオバンキング機器の機能を強化し、市場の成長を促進しています。
• 研究イニシアチブの拡大：ゲノム研究、医薬品開発、再生医療などの研究イニシアチブの拡大により、高度なバイオバンク・ソリューションに対する需要が高まっています。
• 政府からの資金援助：バイオバンクのインフラや研究プログラムに対する政府の支援や資金提供は、バイオバンキング機器市場の成長に寄与しています。
• 意識の高まり：研究やヘルスケアにおけるバイオバンクの重要性に関する調査の高まりは、バイオバンク技術の投資と採用を促進します。

バイオバンキング機器市場の課題は以下の通りである：

• 初期コストの高さ：高度なバイオバンキング機器の高額なコストは、小規模機関や新興市場にとって障壁となる可能性があります。
• 規制遵守：バイオバンク業務に関する複雑な規制要件をクリアすることは困難であり、市場参入に影響を与える可能性があります。
• データ・セキュリティへの懸念：機密性の高い生物学的データのセキュリティとプライバシーの確保は、バイオバンク運営者にとって課題となり、市場の信頼に影響を与えます。

これらの促進要因・課題が総合的にバイオバンキング機器市場を形成し、その成長軌道と市場開拓に影響を与えます。

目次

第1章 エグゼクティブサマリー

第2章 世界のバイオバンキング機器市場：市場力学

• イントロダクション、背景、分類
• サプライチェーン
• 業界の促進要因と課題

第3章 市場動向と予測分析 (2019年～2031年)

• マクロ経済動向 (2019～2024年) と予測 (2025～2031年)
• 世界のバイオバンキング機器市場の動向 (2019～2024年) と予測 (2025～2031年)
• 世界のバイオバンキング機器市場：製品種類別
  • 装置
  • 消耗品
  • ソフトウェア
  • サービス
• 世界のバイオバンキング機器市場：試料の種類別
  • 血液製品
  • 人体組織
  • 臍帯血幹細胞
  • デオキシリボ核酸
  • 細胞株
• 世界のバイオバンキング機器市場：用途別
  • 再生医療
  • 創薬・臨床研究
  • 診断
• 世界のバイオバンキング機器市場：最終用途別
  • 製薬
  • バイオバンク
  • 病院
  • CRO (医薬品開発業務受託機関)
  • その他

第4章 地域別の市場動向と予測分析 (2019年～2031年)

• 世界のバイオバンキング機器市場：地域別
• 北米のバイオバンキング機器市場
• 欧州のバイオバンキング機器市場
• アジア太平洋のバイオバンキング機器市場
• その他地域のバイオバンキング機器市場

第5章 競合分析

• 製品ポートフォリオ分析
• 運用統合
• ポーターのファイブフォース分析

第6章 成長機会と戦略分析

• 成長機会分析
  • 世界のバイオバンキング機器市場の成長機会：製品種類別
  • 世界のバイオバンキング機器市場の成長機会：試料の種類別
  • 世界のバイオバンキング機器市場の成長機会：用途別
  • 世界のバイオバンキング機器市場の成長機会：種類別
  • 世界のバイオバンキング機器市場の成長機会：地域別
• 世界のバイオバンキング機器市場の新たな動向
• 戦略的分析
  • 新製品の開発
  • 世界のバイオバンキング機器市場の生産能力拡大
  • 世界のバイオバンキング機器市場における企業合併・買収 (M&A)、合弁事業
  • 認証とライセンシング

第7章 主要企業のプロファイル

• Thermo Fisher Scientific
• Brooks Automation
• TTP Labtech
• VWR International
• Chart Industries
• Sigma-Aldrich
• Panasonic Healthcare
• Thermo Fisher Scientific
• Qiagen
• Hamilton Storage Technologies

The future of the global biobanking equipment market looks promising with opportunities in the pharmaceutical, biobank, hospital, and contract research organization markets. The global biobanking equipment market is expected to reach an estimated $52 billion by 2031 with a CAGR of 4.1% from 2025 to 2031. The major drivers for this market are growing investments and funding for biobanks, rising prevalence of chronic diseases, and expanding demand for personalized medicine.

• Lucintel forecasts that, within the application category, the regenerative medicine segment is expected to witness the highest growth over the forecast period.
• Within the end use category, contract research organization is expected to witness the highest growth over the forecast period.
• In terms of region, North America will remain the largest region over the forecast period.

Gain valuable insights for your business decisions with our comprehensive 150+ page report.

Emerging Trends in the Biobanking Equipment Market

The biobanking equipment market is witnessing several emerging trends driven by technological advancements and increasing research demands. These trends are shaping the future of biobanking by enhancing efficiency and expanding capabilities.

• AI and Machine Learning Integration: AI and machine learning are being increasingly integrated into biobanking equipment for advanced data analysis and sample management. This trend improves predictive analytics and enhances the efficiency of sample-handling processes.
• Automation and Robotics: The use of automation and robotics in biobanking is growing, enabling high-throughput processing and reducing human error. Automated systems enhance efficiency in sample collection, storage, and retrieval, supporting large-scale research projects.
• Cloud-Based Data Management: Cloud-based solutions are being adopted for managing biobank data, facilitating real-time access and collaboration across research institutions. This trend improves data security and accessibility, supporting global research initiatives.
• Sustainable Practices: There is a growing emphasis on sustainability in biobanking, with the adoption of energy-efficient equipment and eco-friendly materials. Sustainable practices reduce the environmental impact of biobank operations and align with broader environmental goals.
• Personalized Medicine Support: Biobanks are increasingly focusing on supporting personalized medicine through advanced sample tracking and analysis. This trend involves integrating biobank data with genomic and clinical information to tailor treatments to individual patients.

These trends are reshaping the biobanking equipment market by enhancing technological capabilities, improving data management, and supporting personalized healthcare solutions.

Recent Developments in the Biobanking Equipment Market

Recent developments in the biobanking equipment market are driving innovation and improving the efficiency of biobank operations. These advancements are essential for supporting large-scale research and personalized medicine initiatives.

• Advanced Cryopreservation Technologies: New cryopreservation methods are being developed to improve the long-term storage of biological samples. These technologies enhance sample viability and reduce degradation, supporting high-quality research and clinical applications.
• High-Throughput Sample Processing: Innovations in high-throughput processing systems are enabling faster and more efficient handling of large volumes of samples. These systems support large-scale genomic studies and other research initiatives requiring extensive sample analysis.
• Automated Sample Handling Systems: The introduction of automated systems for sample handling is improving the accuracy and efficiency of biobank operations. These systems reduce manual labor and human error, streamlining sample processing and management.
• Integrated Data Management Solutions: Advanced data management solutions are being integrated into biobanking systems, allowing for better data organization and accessibility. These solutions support collaborative research efforts and enhance data sharing among institutions.
• Mobile Biobank Units: Mobile biobank units are being developed to provide biobanking services in remote or underserved areas. These units offer flexible and scalable solutions for sample collection and storage, improving access to biobank services.

These developments are advancing biobank technology, increasing efficiency, and expanding access to biobanking services.

Strategic Growth Opportunities for Biobanking Equipment Market

The biobanking equipment market presents several strategic growth opportunities across various applications. These opportunities are driving innovation and expanding the reach of biobanking services.

• Genomics Research: Biobanks are increasingly supporting genomics research with advanced equipment and data management solutions. This opportunity includes integrating genomic data with biobank samples to support personalized medicine and precision research.
• Clinical Trials: The demand for biobanking equipment in clinical trials is growing, as biobanks provide critical support for sample collection and analysis. This opportunity involves enhancing sample processing and data integration for clinical research.
• Regenerative Medicine: Biobanks are playing a key role in regenerative medicine by providing high-quality biological samples for research and development. Opportunities include developing advanced storage and preservation technologies for regenerative therapies.
• Drug Development: The biobanking market supports drug development by supplying biological samples for preclinical and clinical studies. Growth opportunities include improving sample quality and streamlining data management for drug research.
• Public Health Research: Biobanks are essential for public health research, providing samples for epidemiological studies and disease monitoring. Opportunities include expanding biobank networks and improving data accessibility for public health initiatives.

These growth opportunities are enhancing the capabilities of biobanks, supporting diverse research applications, and driving market expansion.

Biobanking Equipment Market Driver and Challenges

The biobanking equipment market is influenced by various drivers and challenges that impact its growth and development. Understanding these factors is crucial for navigating the market effectively.

The factors responsible for driving the biobanking equipment market include:

• Rising Demand for Personalized Medicine: The increasing focus on personalized medicine drives the need for advanced biobanking equipment to support genomic and clinical research.
• Technological Advancements: Innovations in cryopreservation, automation, and data management are enhancing the capabilities of biobank equipment and driving market growth.
• Growing Research Initiatives: Expanding research initiatives in genomics, drug development, and regenerative medicine create a demand for advanced biobanking solutions.
• Government Funding: Government support and funding for biobank infrastructure and research programs contribute to the growth of the biobanking equipment market.
• Increased Awareness: Rising awareness about the importance of biobanking in research and healthcare drives investment and adoption of biobanking technologies.

Challenges in the biobanking equipment market are:

• High Initial Costs: The high cost of advanced biobanking equipment can be a barrier for smaller institutions and emerging markets.
• Regulatory Compliance: Navigating complex regulatory requirements for biobank operations can be challenging and may impact market entry.
• Data Security Concerns: Ensuring the security and privacy of sensitive biological data poses challenges for biobank operators and impacts market trust.

These drivers and challenges collectively shape the biobanking equipment market, influencing its growth trajectory and development.

List of Biobanking Equipment Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. Through these strategies biobanking equipment companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the biobanking equipment companies profiled in this report include-

• Thermo Fisher Scientific
• Brooks Automation
• TTP Labtech
• VWR International
• Chart Industries
• Sigma-Aldrich
• Panasonic Healthcare
• Thermo Fisher Scientific
• Qiagen
• Hamilton Storage Technologies

Biobanking Equipment by Segment

The study includes a forecast for the global biobanking equipment market by product type, sample type, application, end use, and region.

Biobanking Equipment Market by Product Type [Analysis by Value from 2019 to 2031]:

• Equipment
• Consumables
• Software
• Services

Biobanking Equipment Market by Sample Type [Analysis by Value from 2019 to 2031]:

• Blood Products
• Human Tissues
• Umbilical Cord Blood Stem Cells
• Deoxyribonucleic Acid
• Cell Lines

Biobanking Equipment Market by Application [Analysis by Value from 2019 to 2031]:

• Regenerative Medicine
• Drug Discovery & Clinical Research
• Diagnostics

Biobanking Equipment Market by End Use [Analysis by Value from 2019 to 2031]:

• Pharmaceutical
• Biobanks
• Hospitals
• Contract Research Organizations (CRO)
• Others

Biobanking Equipment Market by Region [Analysis by Value from 2019 to 2031]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

Country Wise Outlook for the Biobanking Equipment Market

Major players in the market are expanding their operations and forming strategic partnerships to strengthen their positions. The below image highlights recent developments by major biobanking equipment producers in key regions: the USA, China, India, Japan, and Germany

• United States: The U.S. is leading in integrating advanced technologies such as automated sample handling systems and cloud-based data management for biobanks. Recent developments focus on improving sample preservation techniques and expanding biobank networks to support large-scale genomic and clinical research.
• China: China is significantly expanding its biobanking infrastructure, with a focus on large-scale biobank initiatives supported by government funding. Innovations include advanced cryopreservation technologies and automated storage systems to manage the increasing volume of biological samples.
• Germany: Germany is investing in state-of-the-art biobanking facilities that feature advanced temperature control systems and high-throughput sample processing. The emphasis is on enhancing data integration and interoperability across biobanks to support collaborative research efforts.
• India: India is rapidly developing its biobanking capabilities with a focus on affordable and scalable solutions. Recent advancements include the adoption of low-cost cryopreservation methods and mobile biobank units to improve access to biobanking services in remote areas.
• Japan: Japan is at the forefront of integrating AI and machine learning in biobank operations, enhancing sample analysis and data management. Innovations include high-precision storage solutions and advanced analytics platforms to support personalized medicine and genomics research.

Features of the Global Biobanking Equipment Market

Market Size Estimates: Biobanking equipment market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2019 to 2024) and forecast (2025 to 2031) by various segments and regions.

Segmentation Analysis: Biobanking equipment market size by various segments, such as by product type, sample type, application, end use, and region in terms of value ($B).

Regional Analysis: Biobanking equipment market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different product types, sample types, applications, end uses, and regions for the biobanking equipment market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the biobanking equipment market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

This report answers following 11 key questions:

• Q.1. What are some of the most promising, high-growth opportunities for the biobanking equipment market by product type (equipment, consumables, software, and services), sample type (blood products, human tissues, umbilical cord blood stem cells, deoxyribonucleic acid, and cell lines), application (regenerative medicine, drug discovery & clinical research, and diagnostics), end use (pharmaceutical, biobanks, hospitals, contract research organizations (CRO), and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
• Q.2. Which segments will grow at a faster pace and why?
• Q.3. Which region will grow at a faster pace and why?
• Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
• Q.5. What are the business risks and competitive threats in this market?
• Q.6. What are the emerging trends in this market and the reasons behind them?
• Q.7. What are some of the changing demands of customers in the market?
• Q.8. What are the new developments in the market? Which companies are leading these developments?
• Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
• Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
• Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Biobanking Equipment Market: Market Dynamics

• 2.1: Introduction, Background, and Classifications
• 2.2: Supply Chain
• 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2019 to 2031

• 3.1. Macroeconomic Trends (2019-2024) and Forecast (2025-2031)
• 3.2. Global Biobanking Equipment Market Trends (2019-2024) and Forecast (2025-2031)
• 3.3: Global Biobanking Equipment Market by Product Type
  • 3.3.1: Equipment
  • 3.3.2: Consumables
  • 3.3.3: Software
  • 3.3.4: Services
• 3.4: Global Biobanking Equipment Market by Sample Type
  • 3.4.1: Blood Products
  • 3.4.2: Human Tissues
  • 3.4.3: Umbilical Cord Blood Stem Cells
  • 3.4.4: Deoxyribonucleic Acid
  • 3.4.5: Cell Lines
• 3.5: Global Biobanking Equipment Market by Application
  • 3.5.1: Regenerative Medicine
  • 3.5.2: Drug Discovery & Clinical Research
  • 3.5.3: Diagnostics
• 3.6: Global Biobanking Equipment Market by End Use
  • 3.6.1: Pharmaceutical
  • 3.6.2: Biobanks
  • 3.6.3: Hospitals
  • 3.6.4: Contract Research Organizations (CRO)
  • 3.6.5: Others

4. Market Trends and Forecast Analysis by Region from 2019 to 2031

• 4.1: Global Biobanking Equipment Market by Region
• 4.2: North American Biobanking Equipment Market
  • 4.2.1: North American Biobanking Equipment Market by Application: Regenerative Medicine, Drug Discovery & Clinical Research, and Diagnostics
  • 4.2.2: North American Biobanking Equipment Market by End Use: Pharmaceutical, Biobanks, Hospitals, Contract Research Organizations (CRO), and Others
• 4.3: European Biobanking Equipment Market
  • 4.3.1: European Biobanking Equipment Market by Application: Regenerative Medicine, Drug Discovery & Clinical Research, and Diagnostics
  • 4.3.2: European Biobanking Equipment Market by End Use: Pharmaceutical, Biobanks, Hospitals, Contract Research Organizations (CRO), and Others
• 4.4: APAC Biobanking Equipment Market
  • 4.4.1: APAC Biobanking Equipment Market by Application: Regenerative Medicine, Drug Discovery & Clinical Research, and Diagnostics
  • 4.4.2: APAC Biobanking Equipment Market by End Use: Pharmaceutical, Biobanks, Hospitals, Contract Research Organizations (CRO), and Others
• 4.5: ROW Biobanking Equipment Market
  • 4.5.1: ROW Biobanking Equipment Market by Application: Regenerative Medicine, Drug Discovery & Clinical Research, and Diagnostics
  • 4.5.2: ROW Biobanking Equipment Market by End Use: Pharmaceutical, Biobanks, Hospitals, Contract Research Organizations (CRO), and Others

5. Competitor Analysis

• 5.1: Product Portfolio Analysis
• 5.2: Operational Integration
• 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

• 6.1: Growth Opportunity Analysis
  • 6.1.1: Growth Opportunities for the Global Biobanking Equipment Market by Product Type
  • 6.1.2: Growth Opportunities for the Global Biobanking Equipment Market by Sample Type
  • 6.1.3: Growth Opportunities for the Global Biobanking Equipment Market by Application
  • 6.1.4: Growth Opportunities for the Global Biobanking Equipment Market by End Use
  • 6.1.5: Growth Opportunities for the Global Biobanking Equipment Market by Region
• 6.2: Emerging Trends in the Global Biobanking Equipment Market
• 6.3: Strategic Analysis
  • 6.3.1: New Product Development
  • 6.3.2: Capacity Expansion of the Global Biobanking Equipment Market
  • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Biobanking Equipment Market
  • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

• 7.1: Thermo Fisher Scientific
• 7.2: Brooks Automation
• 7.3: TTP Labtech
• 7.4: VWR International
• 7.5: Chart Industries
• 7.6: Sigma-Aldrich
• 7.7: Panasonic Healthcare
• 7.8: Thermo Fisher Scientific
• 7.9: Qiagen
• 7.10: Hamilton Storage Technologies